As shown in Table 2, among patients with lymph node metastases, six out of 19 (31.58%) expressed CCN5 positively, compared to 25 out of 33 (75.76%) in patients without lymph node metastases. The gene discussed is CCN5; the disease is metastatic malignant neoplasm in the lymph nodes.